1. P454: VENETOCLAX AND GILTERITINIB SYNERGIZE IN FLT3 WILDTYPE ACUTE MYELOID LEUKEMIA BY SUPPRESSION OF MCL-1 VIA COMBINED AXL AND FLT3 TARGETING. (23rd June 2022) Authors: Schmidt, C.; Janssen, M.; Bruch, P.-M.; Blank, M. F.; Rohde, C.; Waclawiczek, A.; Renders, S.; Heid, D.; Göllner, S.; Vierbaum, L.; Weidenauer, K.; Herbst, S.; Knoll, M.; Kolb, C.; Besenbeck, B.; Fabre, M.; Gu, M.; Schlenk, R.; Stölzel, F.; Bornhäuser, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗